BIOMAT Database Logo BIOMAT Database Logo

Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease. 1991

E Ikonen, and M Baumann, and K Grön, and A C Syvänen, and N Enomaa, and R Halila, and P Aula, and L Peltonen
National Public Health Institute, Laboratory of Molecular Genetics, Helsinki, Finland.

We have isolated a 2.1 kb cDNA which encodes human aspartylglucosaminidase (AGA, E.C. 3.5.1.26). The activity of this lysosomal enzyme is deficient in aspartylglucosaminuria (AGU), a recessively inherited lysosomal accumulation disease resulting in severe mental retardation. The polypeptide chain deduced from the AGA cDNA consists of 346 amino acids, has two potential N-glycosylation sites and 11 cysteine residues. Transient expression of this cDNA in COS-1 cells resulted in increased expression of immunoprecipitable AGA protein. Direct sequencing of amplified AGA cDNA from an AGU patient revealed a G----C transition resulting in the substitution of cysteine 163 with serine. This mutation was subsequently found in all the 20 analyzed Finnish AGU patients, in the heterozygous form in all 53 carriers and in none of 67 control individuals, suggesting that it represents the major AGU causing mutation enriched in this isolated population. Since the mutation produces a change in the predicted flexibility of the AGA polypeptide chain and removes an intramolecular S-S bridge, it most probably explains the deficient enzyme activity found in cells and tissues of AGU patients.

UI MeSH Term Description Entries
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002239 Carbohydrate Metabolism, Inborn Errors Dysfunctions of CARBOHYDRATE METABOLISM resulting from inborn genetic mutations that are inherited or acquired in utero. Carbohydrate Metabolism, Inborn Error
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002894 Chromosomes, Human, Pair 4 A specific pair of GROUP B CHROMOSOMES of the human chromosome classification. Chromosome 4
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA

Related Publications

E Ikonen, and M Baumann, and K Grön, and A C Syvänen, and N Enomaa, and R Halila, and P Aula, and L Peltonen
Identification of a novel mutation causing aspartylglucosaminuria reveals a mutation hotspot region in the aspartylglucosaminidase gene.
January 1995, Human mutation,
E Ikonen, and M Baumann, and K Grön, and A C Syvänen, and N Enomaa, and R Halila, and P Aula, and L Peltonen
A novel aspartylglucosaminuria mutation affects translocation of aspartylglucosaminidase.
October 2004, Human mutation,
E Ikonen, and M Baumann, and K Grön, and A C Syvänen, and N Enomaa, and R Halila, and P Aula, and L Peltonen
Expression of aspartylglucosaminidase in human tissues from normal individuals and aspartylglucosaminuria patients.
July 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society,
E Ikonen, and M Baumann, and K Grön, and A C Syvänen, and N Enomaa, and R Halila, and P Aula, and L Peltonen
Human aspartylglucosaminidase. A biochemical and immunocytochemical characterization of the enzyme in normal and aspartylglucosaminuria fibroblasts.
September 1992, The Biochemical journal,
E Ikonen, and M Baumann, and K Grön, and A C Syvänen, and N Enomaa, and R Halila, and P Aula, and L Peltonen
Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease.
October 1993, Nature genetics,
E Ikonen, and M Baumann, and K Grön, and A C Syvänen, and N Enomaa, and R Halila, and P Aula, and L Peltonen
Aspartylglucosaminuria (AGU): protein and gene structure of normal and mutated aspartylglucosaminidase.
August 1993, Biochemical medicine and metabolic biology,
E Ikonen, and M Baumann, and K Grön, and A C Syvänen, and N Enomaa, and R Halila, and P Aula, and L Peltonen
[Molecular analysis of the aspartylglucosaminidase gene in Japanese patients with aspartylglucosaminuria].
September 1993, Nihon rinsho. Japanese journal of clinical medicine,
E Ikonen, and M Baumann, and K Grön, and A C Syvänen, and N Enomaa, and R Halila, and P Aula, and L Peltonen
Mutations causing aspartylglucosaminuria (AGU): a lysosomal accumulation disease.
January 1992, Human mutation,
E Ikonen, and M Baumann, and K Grön, and A C Syvänen, and N Enomaa, and R Halila, and P Aula, and L Peltonen
Aspartylglucosaminuria: deficiency of aspartylglucosaminidase in cultured fibroblasts of patients and their heterozygous parents.
January 1973, Clinical genetics,
E Ikonen, and M Baumann, and K Grön, and A C Syvänen, and N Enomaa, and R Halila, and P Aula, and L Peltonen
Toward understanding the neuronal pathogenesis of aspartylglucosaminuria: expression of aspartylglucosaminidase in brain during development.
August 1999, Molecular genetics and metabolism,
Copied contents to your clipboard!